Company overview
Basic information
Company name
Gelžmedis, MB
Company code
306969685
Registered address
Kėdainių r. sav., Šėta, Ramygalos g. 26, LT-58130
Registration date
2024-08-12
Company age: 2 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Manufacture of metal structures and parts of structures
Ownership form
Private without foreign capital
MB Gelžmedis
Company code: 306969685
Address: Kėdainių r. sav., Šėta, Ramygalos g. 26, LT-58130
Description
This description was generated by artificial intelligence.
Gelžmedis, MB (company code 306969685) is an operational private small partnership registered on 12 August 2024. It is a Lithuanian-owned private company within the national private non-financial companies sector, governed by a CEO only and classified as a micro-sized business. The company is based at Ramygalos g. 26, Šeta, Kedainiu r. sav., Kauno apskr. Its registered activity under EVRK code C.25.11.00 is manufacture of metal structures and parts of structures.
Financially, the company recorded revenue of EUR 8.3K in 2025, down 19.6% year on year from EUR 10.3K in 2024. It reported a net loss of EUR 1.0K in 2025, compared with a net profit of EUR 2.2K in 2024, and its profit margin moved from 20.9% to -12.3%. At the end of 2025, equity stood at EUR 800 and total assets at EUR 930, supported by EUR 866 in long-term assets and EUR 64 in short-term assets. Liabilities were EUR 130. Staff information is referenced for 2026 so far, but no employee average is provided in the available data.
Financially, the company recorded revenue of EUR 8.3K in 2025, down 19.6% year on year from EUR 10.3K in 2024. It reported a net loss of EUR 1.0K in 2025, compared with a net profit of EUR 2.2K in 2024, and its profit margin moved from 20.9% to -12.3%. At the end of 2025, equity stood at EUR 800 and total assets at EUR 930, supported by EUR 866 in long-term assets and EUR 64 in short-term assets. Liabilities were EUR 130. Staff information is referenced for 2026 so far, but no employee average is provided in the available data.
Download a detailed company report
Make confident decisions with all the information about Gelžmedis, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.